 | • レポートコード：QYR9ST02397 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界の皮膚科薬市場について調査・分析し、以下の構成でお届け致します。皮膚科薬の種類別には、処方薬、市販薬に、用途別には、にきび、皮膚感染症、乾癬、皮膚炎薬、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別皮膚科薬売上データ ・地域別皮膚科薬市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別皮膚科薬市場規模：処方薬、市販薬 ・用途別皮膚科薬市場規模：にきび、皮膚感染症、乾癬、皮膚炎薬、その他 ・主要メーカーの企業情報：Bayer、Johnson & Johnson、Pfizer、Novartis、GlaxoSmithKline、AstraZeneca、Galderma、Amgen、AbbVie、Merck ・皮膚科薬の市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
Dermatology is a field of medicine that is engaged in the diagnosis, prevention, and treatment of various skin, nails, hair diseases, pigmentation, acne, wrinkles, psoriasis, and others.Different techniques are used in dermatology such as topical & systemic medications, laser therapy, radio therapy, photodynamic therapy, vitiligo surgery, dermatological surgery, and others.
The global Dermatological Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Dermatological Drugs market based on company, product type, end user and key regions.
This report studies the global market size of Dermatological Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Dermatological Drugs in these regions.
This research report categorizes the global Dermatological Drugs market by top players/brands, region, type and end user. This report also studies the global Dermatological Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Bayer
Johnson & Johnson
Pfizer
Novartis
GlaxoSmithKline
AstraZeneca
Galderma
Amgen
AbbVie
Merck
Market size by Product
By drug type
Prescription-Based Drugs
Over-the-Counter Drugs
By route of administration
Topical Administration
Oral Administration
Parenteral Administration
By dermatological diseases
Acne
Dermatitis
Psoriasis
Skin Cancer
Rosacea
Alopecia
Others
Market size by End User
Acne
Skin Infections
Psoriasis
Dermatitis Drugs
Other
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Dermatological Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Dermatological Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Dermatological Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Dermatological Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Dermatological Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Dermatological Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Dermatological Drugs Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Dermatological Drugs Market Size Growth Rate by Product
1.4.2 Prescription-Based Drugs
1.4.3 Over-the-Counter Drugs
1.5 Market by End User
1.5.1 Global Dermatological Drugs Market Size Growth Rate by End User
1.5.2 Acne
1.5.3 Skin Infections
1.5.4 Psoriasis
1.5.5 Dermatitis Drugs
1.5.6 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Dermatological Drugs Market Size
2.1.1 Global Dermatological Drugs Revenue 2014-2025
2.1.2 Global Dermatological Drugs Sales 2014-2025
2.2 Dermatological Drugs Growth Rate by Regions
2.2.1 Global Dermatological Drugs Sales by Regions
2.2.2 Global Dermatological Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Dermatological Drugs Sales by Manufacturers
3.1.1 Dermatological Drugs Sales by Manufacturers
3.1.2 Dermatological Drugs Sales Market Share by Manufacturers
3.1.3 Global Dermatological Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Dermatological Drugs Revenue by Manufacturers
3.2.1 Dermatological Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Dermatological Drugs Revenue Share by Manufacturers (2014-2019)
3.3 Dermatological Drugs Price by Manufacturers
3.4 Dermatological Drugs Manufacturing Base Distribution, Product Types
3.4.1 Dermatological Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Dermatological Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Dermatological Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Dermatological Drugs Sales by Product
4.2 Global Dermatological Drugs Revenue by Product
4.3 Dermatological Drugs Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Dermatological Drugs Breakdown Data by End User
6 North America
6.1 North America Dermatological Drugs by Countries
6.1.1 North America Dermatological Drugs Sales by Countries
6.1.2 North America Dermatological Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Dermatological Drugs by Product
6.3 North America Dermatological Drugs by End User
7 Europe
7.1 Europe Dermatological Drugs by Countries
7.1.1 Europe Dermatological Drugs Sales by Countries
7.1.2 Europe Dermatological Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Dermatological Drugs by Product
7.3 Europe Dermatological Drugs by End User
8 Asia Pacific
8.1 Asia Pacific Dermatological Drugs by Countries
8.1.1 Asia Pacific Dermatological Drugs Sales by Countries
8.1.2 Asia Pacific Dermatological Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Dermatological Drugs by Product
8.3 Asia Pacific Dermatological Drugs by End User
9 Central & South America
9.1 Central & South America Dermatological Drugs by Countries
9.1.1 Central & South America Dermatological Drugs Sales by Countries
9.1.2 Central & South America Dermatological Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Dermatological Drugs by Product
9.3 Central & South America Dermatological Drugs by End User
10 Middle East and Africa
10.1 Middle East and Africa Dermatological Drugs by Countries
10.1.1 Middle East and Africa Dermatological Drugs Sales by Countries
10.1.2 Middle East and Africa Dermatological Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Dermatological Drugs by Product
10.3 Middle East and Africa Dermatological Drugs by End User
11 Company Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Company Business Overview
11.1.3 Bayer Dermatological Drugs Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Bayer Dermatological Drugs Products Offered
11.1.5 Bayer Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Company Business Overview
11.2.3 Johnson & Johnson Dermatological Drugs Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Johnson & Johnson Dermatological Drugs Products Offered
11.2.5 Johnson & Johnson Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Company Business Overview
11.3.3 Pfizer Dermatological Drugs Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Pfizer Dermatological Drugs Products Offered
11.3.5 Pfizer Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Company Business Overview
11.4.3 Novartis Dermatological Drugs Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Novartis Dermatological Drugs Products Offered
11.4.5 Novartis Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 Company Business Overview
11.5.3 GlaxoSmithKline Dermatological Drugs Sales, Revenue and Gross Margin (2014-2019)
11.5.4 GlaxoSmithKline Dermatological Drugs Products Offered
11.5.5 GlaxoSmithKline Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 Company Business Overview
11.6.3 AstraZeneca Dermatological Drugs Sales, Revenue and Gross Margin (2014-2019)
11.6.4 AstraZeneca Dermatological Drugs Products Offered
11.6.5 AstraZeneca Recent Development
11.7 Galderma
11.7.1 Galderma Company Details
11.7.2 Company Business Overview
11.7.3 Galderma Dermatological Drugs Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Galderma Dermatological Drugs Products Offered
11.7.5 Galderma Recent Development
11.8 Amgen
11.8.1 Amgen Company Details
11.8.2 Company Business Overview
11.8.3 Amgen Dermatological Drugs Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Amgen Dermatological Drugs Products Offered
11.8.5 Amgen Recent Development
11.9 AbbVie
11.9.1 AbbVie Company Details
11.9.2 Company Business Overview
11.9.3 AbbVie Dermatological Drugs Sales, Revenue and Gross Margin (2014-2019)
11.9.4 AbbVie Dermatological Drugs Products Offered
11.9.5 AbbVie Recent Development
11.10 Merck
11.10.1 Merck Company Details
11.10.2 Company Business Overview
11.10.3 Merck Dermatological Drugs Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Merck Dermatological Drugs Products Offered
11.10.5 Merck Recent Development
12 Future Forecast
12.1 Dermatological Drugs Market Forecast by Regions
12.1.1 Global Dermatological Drugs Sales Forecast by Regions 2019-2025
12.1.2 Global Dermatological Drugs Revenue Forecast by Regions 2019-2025
12.2 Dermatological Drugs Market Forecast by Product
12.2.1 Global Dermatological Drugs Sales Forecast by Product 2019-2025
12.2.2 Global Dermatological Drugs Revenue Forecast by Product 2019-2025
12.3 Dermatological Drugs Market Forecast by End User
12.4 North America Dermatological Drugs Forecast
12.5 Europe Dermatological Drugs Forecast
12.6 Asia Pacific Dermatological Drugs Forecast
12.7 Central & South America Dermatological Drugs Forecast
12.8 Middle East and Africa Dermatological Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Dermatological Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Dermatological Drugs Product Picture
Table Dermatological Drugs Market Segments
Table Key Manufacturers Dermatological Drugs Covered
Table Global Dermatological Drugs Market Size Growth Rate by Product 2019-2025 (MT) & (Million US$)
Figure Global Dermatological Drugs Sales Market Share by Product 2014-2025
Figure Prescription-Based Drugs Product Picture
Table Major Manufacturers of Prescription-Based Drugs
Figure Over-the-Counter Drugs Product Picture
Table Major Manufacturers of Over-the-Counter Drugs
Table Global Dermatological Drugs Market Size Growth Rate by End User 2019-2025 (MT)
Figure Acne
Figure Skin Infections
Figure Psoriasis
Figure Dermatitis Drugs
Figure Other
Figure Dermatological Drugs Report Years Considered
Figure Global Dermatological Drugs Market Size 2014-2025 (Million US$)
Figure Global Dermatological Drugs Sales 2014-2025 (MT)
Table Global Dermatological Drugs Market Size by Regions 2014-2019 (MT) & (Million US$)
Table Global Dermatological Drugs Sales by Regions 2014-2019 (MT)
Table Global Dermatological Drugs Sales Market Share by Regions 2014-2019
Figure Global Dermatological Drugs Sales Market Share by Regions 2014-2019
Figure 2018 Global Dermatological Drugs Sales Market Share by Regions
Table Global Dermatological Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Dermatological Drugs Revenue Market Share by Regions 2014-2019
Figure Global Dermatological Drugs Revenue Market Share by Regions 2014-2019
Figure 2018 Global Dermatological Drugs Revenue Market Share by Regions
Table Global Dermatological Drugs Sales by Manufacturers (2014-2019) (MT)
Table Global Dermatological Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Dermatological Drugs Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Dermatological Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Dermatological Drugs Revenue Share by Manufacturers (2014-2019)
Figure Dermatological Drugs Value Share by Manufacturers in 2018
Table Key Manufacturers Dermatological Drugs Price (2014-2019) (USD/Kg)
Table Dermatological Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Dermatological Drugs Product Type
Table Date of International Manufacturers Enter into Dermatological Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Dermatological Drugs Sales by Product (2014-2019) (MT)
Table Global Dermatological Drugs Sales Share by Product (2014-2019)
Figure Global Dermatological Drugs Sales Market Share by Product (2014-2019)
Figure Global Dermatological Drugs Sales Market Share by Product in 2018
Table Global Dermatological Drugs Revenue by Product (2014-2019) (Million US$)
Table Global Dermatological Drugs Revenue Share by Product (2014-2019)
Figure Global Dermatological Drugs Revenue Market Share by Product (2014-2019)
Figure Global Dermatological Drugs Revenue Market Share by Product in 2018
Table Dermatological Drugs Price by Product 2014-2019 (USD/Kg)
Table Global Dermatological Drugs Sales by End User (2014-2019) (MT)
Table Global Dermatological Drugs Sales Share by End User (2014-2019)
Figure Global Sales Dermatological Drugs Market Share by End User (2014-2019)
Figure Global Sales Dermatological Drugs Market Share by End User in 2018
Figure North America Dermatological Drugs Sales Growth Rate 2014-2019 (MT)
Figure North America Dermatological Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table North America Dermatological Drugs Sales by Countries (2014-2019) (MT)
Table North America Dermatological Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 North America Dermatological Drugs Sales Market Share by Countries
Table North America Dermatological Drugs Revenue by Countries (2014-2019) (Million US$)
Table North America Dermatological Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Dermatological Drugs Revenue Market Share by Countries
Figure United States Dermatological Drugs Sales Growth Rate (2014-2019) (MT)
Figure United States Dermatological Drugs Revenue Growth Rate (2014-2019) (MT)
Figure Canada Dermatological Drugs Sales Growth Rate (2014-2019) (MT)
Figure Canada Dermatological Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Dermatological Drugs Sales Growth Rate (2014-2019) (MT)
Figure Mexico Dermatological Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table North America Dermatological Drugs Sales by Product (2014-2019) (MT)
Table North America Dermatological Drugs Sales Market Share by Product (2014-2019)
Figure 2018 North America Dermatological Drugs Market Share by Product
Table North America Dermatological Drugs Sales by End User (2014-2019) (MT)
Table North America Dermatological Drugs Sales Market Share by End User (2014-2019)
Figure 2018 North America Dermatological Drugs Market Share by End User
Figure Europe Dermatological Drugs Sales Growth Rate 2014-2019 (MT)
Figure Europe Dermatological Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Dermatological Drugs Sales by Countries (2014-2019) (MT)
Table Europe Dermatological Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Dermatological Drugs Sales Market Share by Countries
Table Europe Dermatological Drugs Revenue by Countries (2014-2019) (Million US$)
Table Europe Dermatological Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Dermatological Drugs Revenue Market Share by Countries
Figure Germany Dermatological Drugs Sales Growth Rate (2014-2019) (MT)
Figure Germany Dermatological Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure France Dermatological Drugs Sales Growth Rate (2014-2019) (MT)
Figure France Dermatological Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Dermatological Drugs Sales Growth Rate (2014-2019) (MT)
Figure UK Dermatological Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Dermatological Drugs Sales Growth Rate (2014-2019) (MT)
Figure Italy Dermatological Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Dermatological Drugs Sales Growth Rate (2014-2019) (MT)
Figure Russia Dermatological Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Dermatological Drugs Sales by Product (2014-2019) (MT)
Table Europe Dermatological Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Europe Dermatological Drugs Market Share by Product
Table Europe Dermatological Drugs Sales by End User (2014-2019) (MT)
Table Europe Dermatological Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Europe Dermatological Drugs Market Share by End User
Figure Asia Pacific Dermatological Drugs Sales Growth Rate 2014-2019 (MT)
Figure Asia Pacific Dermatological Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Dermatological Drugs Sales by Countries (2014-2019) (MT)
Table Asia Pacific Dermatological Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Dermatological Drugs Sales Market Share by Countries
Table Asia Pacific Dermatological Drugs Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Dermatological Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Dermatological Drugs Revenue Market Share by Countries
Figure China Dermatological Drugs Sales Growth Rate (2014-2019) (MT)
Figure China Dermatological Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Dermatological Drugs Sales Growth Rate (2014-2019) (MT)
Figure Japan Dermatological Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Dermatological Drugs Sales Growth Rate (2014-2019) (MT)
Figure Korea Dermatological Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure India Dermatological Drugs Sales Growth Rate (2014-2019) (MT)
Figure India Dermatological Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Dermatological Drugs Sales Growth Rate (2014-2019) (MT)
Figure Australia Dermatological Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Dermatological Drugs Sales Growth Rate (2014-2019) (MT)
Figure Indonesia Dermatological Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Dermatological Drugs Sales Growth Rate (2014-2019) (MT)
Figure Malaysia Dermatological Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Dermatological Drugs Sales Growth Rate (2014-2019) (MT)
Figure Philippines Dermatological Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Dermatological Drugs Sales Growth Rate (2014-2019) (MT)
Figure Thailand Dermatological Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Dermatological Drugs Sales Growth Rate (2014-2019) (MT)
Figure Vietnam Dermatological Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Dermatological Drugs Sales Growth Rate (2014-2019) (MT)
Figure Singapore Dermatological Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Dermatological Drugs Sales by Product (2014-2019) (MT)
Table Asia Pacific Dermatological Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Dermatological Drugs Market Share by Product
Table Asia Pacific Dermatological Drugs Sales by End User (2014-2019) (MT)
Table Asia Pacific Dermatological Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Dermatological Drugs Market Share by End User
Figure Central & South America Dermatological Drugs Sales Growth Rate 2014-2019 (MT)
Figure Central & South America Dermatological Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Dermatological Drugs Sales by Countries (2014-2019) (MT)
Table Central & South America Dermatological Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Dermatological Drugs Sales Market Share by Countries
Table Central & South America Dermatological Drugs Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Dermatological Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Dermatological Drugs Revenue Market Share by Countries
Figure Brazil Dermatological Drugs Sales Growth Rate (2014-2019) (MT)
Figure Brazil Dermatological Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Dermatological Drugs Sales Growth Rate (2014-2019) (MT)
Figure Argentina Dermatological Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Dermatological Drugs Sales by Product (2014-2019) (MT)
Table Central & South America Dermatological Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Dermatological Drugs Market Share by Product
Table Central & South America Dermatological Drugs Sales by End User (2014-2019) (MT)
Table Central & South America Dermatological Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Dermatological Drugs Market Share by End User
Figure Middle East and Africa Dermatological Drugs Sales Growth Rate 2014-2019 (MT)
Figure Middle East and Africa Dermatological Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Dermatological Drugs Sales by Countries (2014-2019) (MT)
Table Middle East and Africa Dermatological Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Dermatological Drugs Sales Market Share by Countries
Table Middle East and Africa Dermatological Drugs Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Dermatological Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Dermatological Drugs Revenue Market Share by Countries
Figure GCC Countries Dermatological Drugs Sales Growth Rate (2014-2019) (MT)
Figure GCC Countries Dermatological Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Dermatological Drugs Sales Growth Rate (2014-2019) (MT)
Figure Turkey Dermatological Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Dermatological Drugs Sales Growth Rate (2014-2019) (MT)
Figure Egypt Dermatological Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Dermatological Drugs Sales Growth Rate (2014-2019) (MT)
Figure South Africa Dermatological Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Dermatological Drugs Sales by Product (2014-2019) (MT)
Table Middle East and Africa Dermatological Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Dermatological Drugs Market Share by Product
Table Middle East and Africa Dermatological Drugs Sales by End User (2014-2019) (MT)
Table Middle East and Africa Dermatological Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Dermatological Drugs Market Share by End User
Table Bayer Company Details
Table Bayer Dermatological Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Bayer Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Dermatological Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Johnson & Johnson Recent Development
Table Pfizer Company Details
Table Pfizer Dermatological Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table Novartis Company Details
Table Novartis Dermatological Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Novartis Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Dermatological Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table GlaxoSmithKline Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Dermatological Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table AstraZeneca Recent Development
Table Galderma Company Details
Table Galderma Dermatological Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Galderma Recent Development
Table Amgen Company Details
Table Amgen Dermatological Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Amgen Recent Development
Table AbbVie Company Details
Table AbbVie Dermatological Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table AbbVie Recent Development
Table Merck Company Details
Table Merck Dermatological Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Merck Recent Development
Table Global Dermatological Drugs Sales Forecast by Regions 2019-2025 (MT)
Table Global Dermatological Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Dermatological Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Dermatological Drugs Revenue Market Share Forecast by Regions 2019-2025
Table Global Dermatological Drugs Sales Forecast by Product 2019-2025 (MT)
Table Global Dermatological Drugs Sales Market Share Forecast by Product 2019-2025
Table Global Dermatological Drugs Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Dermatological Drugs Revenue Market Share Forecast by Product 2019-2025
Table Global Dermatological Drugs Sales Forecast by End User 2019-2025 (MT)
Table Global Dermatological Drugs Sales Market Share Forecast by End User 2019-2025
Figure North America Dermatological Drugs Sales Growth Rate Forecast (2019-2025) (MT)
Figure North America Dermatological Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Dermatological Drugs Sales Growth Rate Forecast (2019-2025) (MT)
Figure Europe Dermatological Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Dermatological Drugs Sales Growth Rate Forecast (2019-2025) (MT)
Figure Asia Pacific Dermatological Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Dermatological Drugs Sales Growth Rate Forecast (2019-2025) (MT)
Figure Central & South America Dermatological Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Dermatological Drugs Sales Growth Rate Forecast (2019-2025) (MT)
Figure Middle East and Africa Dermatological Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Dermatological Drugs Value Chain
Table Dermatological Drugs Customers List
Table Dermatological Drugs Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
アトピー性皮膚炎薬の世界市場：インサイト・予測 Atopic dermatitis (AD) is a pruritic disease of unknown origin that usually starts in early infancy (an adult-onset variant is recognized).One of the major factors responsible for the growing risk of severe atopic dermatitis in infancy is related to food sensitization, which is commonly associated w…- 乾癬薬の世界市場：市場規模・現状・予測 Psoriasis is a genetic condition that may not be present at birth. The condition may be triggered by certain environmental and genetic factors. Changing lifestyles of people are leading to increased alcohol consumption and smoking, unhealthy diet, and sedentary living, which makes people more prone …
- 乾癬薬の世界市場：市場規模・現状・予測 Psoriasis is a genetic condition that may not be present at birth. The condition may be triggered by certain environmental and genetic factors. Changing lifestyles of people are leading to increased alcohol consumption and smoking, unhealthy diet, and sedentary living, which makes people more prone …
- タイサブリ薬の世界市場：インサイト・予測 Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to severe Crohn's disease in adults. Tysabri is usually given after other Crohn's disease medications have been tried without successful treatment of this con…
- 抗肥満処方薬の世界市場：インサイト・予測 Growing demand for obesity is one of the recent trends in the global Anti-Obesity Prescription Drugs market. Moreover, this trend is further anticipated to drive the global Anti-Obesity Prescription Drugs market over the forecast period. Furthermore, growing obesity due unhealthy food and lifestyle …